Pay in 4 interest-free payments of $5.46 Learn more
Ships within 48 hours · Estimated delivery Oct 16 - Oct 21
The study was small (only 11 patients total in the treatment group) so authors conclude that larger trials are needed to determine clinical or statistical significance
They are medicine
FDA Status:Not evaluated or approved by the U
Age-related considerations include: Younger adults (18-30) May tolerate dose escalation well but should still follow standard protocols
Pharmacokinetic Profile Route of Administration Oral Half-Life 24h Route of Administration : Intraperitoneal injection, oral, topical Dosing Frequency : Undetermined in humans Half-Life : Not clinically established
US$ 28.35
US$ 28.82
US$ 28.54
